Clinical trial Recruiting at 1 site Interventional Ages 6 to 13

Comparing electronic spectacles and low dose atropine for myopia in children

Official title: Kubota Corrective Spectacles and Low Dose Atropine for Slowing Myopic Progression in Taiwanese Children

Run by Kubota Vision Inc. · NCT06034379 · Data updated 2026-11-12

This study is testing whether electronic glasses or low-dose atropine can help slow down worsening eyesight in children aged 6 to 13.

Quick facts

Study typeInterventional
Ages6 Years to 13 Years
SexAll
Enrollment45 (estimated)
SponsorKubota Vision Inc.
Industry-sponsored
Locations1 site (Hsinchu)
StatusRecruiting
StartedOctober 1, 2023
Main results expectedDecember 2025
Study endsDecember 2025
Registry record updatedDecember 12, 2024
Trial IDNCT06034379 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 6 to 13 with myopia ranging from -0.50 to -10.00 diopters.

Probably not a fit

Patients with severe eye conditions, systemic diseases, or those currently pregnant or lactating may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of an electronic spectacle prototype and low-dose atropine in slowing myopia progression in children aged 6 to 13. Participants will be randomly assigned to one of three groups: wearing the electronic device alone, wearing it with daily atropine drops, or using atropine drops without the device. The study will measure changes in refractive error and axial length over 12 months, with assessments conducted at multiple time points. The trial aims to provide insights into innovative treatments for myopia in a pediatric population.

Why it matters

Potential benefit: If successful, this study could offer a new approach to managing myopia in children, potentially reducing its progression.

How similar studies have gone: While the use of atropine for myopia management has been studied, the combination with electronic spectacles represents a novel approach that has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. The subject must be between 6 and 13 years of age (inclusive).
2. The subject must appear able and willing to adhere to the instructions set forth in the clinical protocol.
3. The guardian of a minor under 18 years old must read and sign the STATEMENT OF INFORMED CONSENT and be provided a copy of the form. The subject under 18 years old must be willing to assent to the STATEMENT OF INFORMED CONSENT.
4. Spherical component of refraction in the range of -0.50 to -10.00 DS in each eye.
5. Refractive cylinder less than or equal to 2.00 DC in each eye (minus cylinder format).
6. Best corrected distance VA of at least 20/25 in each eye.

Exclusion Criteria:

1. Currently pregnant or lactating
2. History of severe dry eye, strabismus, or amblyopia
3. Any systemic disease (e.g., Sjögren's Syndrome), allergies, infectious disease (e.g., hepatitis, tuberculosis), contagious immunosuppressive diseases (e.g., HIV), autoimmune disease (e.g., diabetes, rheumatoid arthritis), or other diseases, by self-report, which are known to interfere with the participation in the study at the investigator's discretion.
4. Use of systemic or ocular medications (e.g., chronic steroid use) that are known to interfere with vision and ocular accommodation at the investigator's discretion.
5. Any previous, or planned (during the course of the study) ocular surgery (e.g., radial keratotomy, PRK, LASIK, strabismus surgery etc.) or orthokeratology
6. Any active ocular infection.
7. Any accommodative or binocular anomalies including amblyopia.
8. Any physical or mental developmental delay.
9. Any relevant ocular or systemic condition deemed unacceptable by the investigator that may negatively impact the subject's performance or ability to successfully complete the study (at the investigator's discretion)
10. Anisometropia greater than 1.50D

Where it's running

  • CMU Hsinchu Hospital
    Hsinchu, Taiwan
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.